Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0649

+0.6%

Nov 13 3:42 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NTTG who wrote (12311)	8/13/2013 10:28:20 AM
From: jm2i123	Read Replies (1) of 13111

oh I thought Allovectin was the one to follow for PVCT?.. NTTG...hello?? Yahoo!Finance Pvct board Oct 29, 2012 1:01 PM, NTTG says: Allovectin to present on in vivo combination Tx for advanced melanoma...at Mol Med Tri Con meeting at the upcoming Molecular Med Tri Con meeting, Feb 11-15 2013. Nice collection of other immune therapy talks in the session, quite a few MM talks throughout the meeting...nothing from PVCT??? new_to_the_game_00 • Mar 26, 2011 9:25 PM Makes allovectin all the more interesting......IMO

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next